HHS Awards $6.4M for End-Stage Renal Disease Quality Support, Ending Feb 2027
Contract Overview
Contract Amount: $6,422,162 ($6.4M)
Contractor: Arbor Research Collaborative for Health
Awarding Agency: Department of Health and Human Services
Start Date: 2024-03-30
End Date: 2027-02-27
Contract Duration: 1,064 days
Daily Burn Rate: $6.0K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 4
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: END-STAGE RENAL DISEASE QUALITY SUPPORT CONTRACT
Place of Performance
Location: ANN ARBOR, WASHTENAW County, MICHIGAN, 48108
State: Michigan Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $6.4 million to ARBOR RESEARCH COLLABORATIVE FOR HEALTH for work described as: END-STAGE RENAL DISEASE QUALITY SUPPORT CONTRACT Key points: 1. Contract awarded to Arbor Research Collaborative for Health for quality support. 2. Focuses on End-Stage Renal Disease (ESRD) quality improvement initiatives. 3. Competition method is 'Full and Open', suggesting market availability. 4. Sector is primarily healthcare services and data analysis.
Value Assessment
Rating: good
The award amount of $6.42M over approximately 3 years appears reasonable for specialized quality support services in healthcare. Benchmarking against similar contracts for ESRD quality initiatives would provide further context.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating that multiple vendors had the opportunity to bid. This method generally promotes competitive pricing and ensures the government receives best value.
Taxpayer Impact: The investment aims to improve ESRD patient outcomes, potentially reducing long-term healthcare costs for taxpayers through better quality of care.
Public Impact
Enhances quality of care for patients with End-Stage Renal Disease. Supports federal efforts to improve health outcomes and reduce healthcare spending. Leverages specialized expertise in renal disease research and quality improvement.
Waste & Efficiency Indicators
Waste Risk Score: 60 / 10
Warning Flags
- Potential for scope creep in quality improvement initiatives.
- Reliance on a single contractor for critical ESRD data analysis.
Positive Signals
- Clear focus on improving patient outcomes.
- Competitive award process.
- Long-term contract duration allows for sustained impact.
Sector Analysis
This contract falls within the healthcare sector, specifically focusing on quality improvement for End-Stage Renal Disease. Spending in this area is critical for managing chronic conditions and improving patient longevity and quality of life.
Small Business Impact
The data indicates the contract was not set aside for small businesses and was awarded under full and open competition. Therefore, small business participation is not explicitly guaranteed but possible through subcontracting.
Oversight & Accountability
The Centers for Medicare and Medicaid Services (CMS) is responsible for overseeing this contract. Robust oversight will be crucial to ensure the contractor meets performance metrics and delivers on quality improvement goals.
Related Government Programs
- Other Scientific and Technical Consulting Services
- Department of Health and Human Services Contracting
- Centers for Medicare and Medicaid Services Programs
Risk Flags
- Contract duration is substantial, requiring sustained performance monitoring.
- Potential for vendor lock-in if specialized knowledge becomes proprietary.
- Dependence on accurate and timely data from healthcare providers.
- Effectiveness hinges on the contractor's ability to influence provider behavior.
Tags
other-scientific-and-technical-consultin, department-of-health-and-human-services, mi, delivery-order, 1m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $6.4 million to ARBOR RESEARCH COLLABORATIVE FOR HEALTH. END-STAGE RENAL DISEASE QUALITY SUPPORT CONTRACT
Who is the contractor on this award?
The obligated recipient is ARBOR RESEARCH COLLABORATIVE FOR HEALTH.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (Centers for Medicare and Medicaid Services).
What is the total obligated amount?
The obligated amount is $6.4 million.
What is the period of performance?
Start: 2024-03-30. End: 2027-02-27.
What specific metrics will be used to measure the success of the quality support provided?
Success will likely be measured by improvements in key performance indicators related to End-Stage Renal Disease patient outcomes, such as reduced mortality rates, improved quality of life scores, and decreased hospital readmission rates. Specific metrics should be detailed in the contract's statement of work and performance work statement.
What are the primary risks associated with this contract?
Key risks include the potential for the contractor to underperform in achieving quality improvement targets, challenges in data collection and analysis accuracy, and the possibility of unforeseen changes in ESRD treatment guidelines or patient populations that could impact the contract's effectiveness.
How does this contract contribute to the overall effectiveness of the ESRD program?
This contract is designed to directly enhance the effectiveness of the ESRD program by providing specialized expertise to drive quality improvements. By focusing on data-driven insights and actionable strategies, it aims to optimize patient care, reduce complications, and ultimately improve the long-term health and well-being of ESRD beneficiaries.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Management, Scientific, and Technical Consulting Services › Other Scientific and Technical Consulting Services
Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT) › PROFESSIONAL SERVICES
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Offers Received: 4
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 340 E HURON ST STE 300, ANN ARBOR, MI, 48104
Business Categories: Category Business, Corporate Entity Tax Exempt, Nonprofit Organization, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $10,295,499
Exercised Options: $6,422,162
Current Obligation: $6,422,162
Actual Outlays: $4,275,599
Subaward Activity
Number of Subawards: 2
Total Subaward Amount: $1,212,103
Contract Characteristics
Multi-Year Contract: Yes
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: YES
Parent Contract
Parent Award PIID: 75FCMC18D0016
IDV Type: IDC
Timeline
Start Date: 2024-03-30
Current End Date: 2027-02-27
Potential End Date: 2029-02-27 00:00:00
Last Modified: 2026-04-07
More Contracts from Arbor Research Collaborative for Health
- MGT Svcs/Contract & Procurement SUP — $19.5M (Department of Health and Human Services)
- FOR Critical Functions — $18.3M (Department of Health and Human Services)
- Mids Task Order 90644 — $17.4M (Department of Health and Human Services)
View all Arbor Research Collaborative for Health federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →